Repligen (NASDAQ:RGEN) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a sell rating to a hold rating in a research note issued to investors on Friday morning. Other equities analysts also recently issued reports about the stock. Canaccord Genuity Group boosted their target price on shares of Repligen from $165.00 to $170.00 and gave the […]
StockNews.com upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a sell rating to a hold rating in a research note issued to investors on Friday morning. Other equities analysts also recently issued reports about the stock. Canaccord Genuity Group boosted their target price on shares of Repligen from $165.00 to $170.00 and gave the […]
